Smyd3-associated regulatory pathways in cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Seminars in cancer biology"
DOI: 10.1016/j.semcancer.2016.08.008
Abstract: SMYD3 is a member of the SET and MYND-domain family of methyl-transferases, the increased expression of which correlates with poor prognosis in various types of cancer. In liver and colon tumors, SMYD3 is localized in… read more here.
Keywords: smyd3; cancer smyd3; associated regulatory; smyd3 associated ... See more keywords